ACAAI News: Tapinarof Cream, 1% Improves Itch and Sleep in AD

Atopic dermatitis (AD) patients aged 2 and older who used tapinarof cream, 1% (Vtama, Dermavant) showed “early, significant, and meaningful” improvements in itch and sleep, according to results from the ADORING 1 and ADORING 2 trials presented at the 2024 American College of Allergy, Asthma and Immunology Annual Meeting in Boston, MA. Specifically, 31.4% and […]